Picture of Paragon 28 logo

FNA Paragon 28 Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Annual income statement for Paragon 28, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS/A10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue111147181216256
Cost of Revenue
Gross Profit85.9119149173191
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses105158243259297
Operating Profit5.82-10.8-62-42.6-40.8
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5.03-13-67.4-47.6-53.5
Provision for Income Taxes
Net Income After Taxes3.5-13.7-67.3-47.8-54.6
Net Income Before Extraordinary Items
Net Income3.5-13.7-67.3-47.8-54.6
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income2.69-13.7-67.3-47.8-54.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.035-0.172-0.642-0.541-0.648
Dividends per Share